- Revolution Medicines ( NASDAQ: RVMD ) has priced an upsized $230M common stock offering at $20 per share.
- The underwritten public offering is for 115M shares. Underwriters have the opportunity to purchase an additional 1.725M shares.
- The offering is expected to close July 22.
- The biotech after Tuesday's closed initially said the offering would be $200M .
- Shares fell more than 10% in post-market trading to $22.02 after the offering announcement.
- Seeking Alpha's Quant Rating views Revolution Medicines ( RVMD ) as a buy with high marks for momentum and profitability .
For further details see:
Revolution Medicines prices upsized $230M equity offering